As per the latest market research conducted by FMI, the global phosphatidylserine market is expected to record a CAGR of 5.3% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of USD 178.19 million. By 2033, the valuation is anticipated to reach USD 298.1 million.
The phosphatidylserine market is witnessing significant growth, driven by the rising awareness of its cognitive health benefits and expanding applications in dietary supplements, functional foods, and pharmaceuticals. Phosphatidylserine, a phospholipid commonly found in cell membranes, is recognized for supporting brain health, improving memory, and reducing symptoms of age-related cognitive decline. This natural compound is increasingly sought after by health-conscious consumers, particularly in regions with aging populations, such as North America and Europe.
Key factors influencing the market include the growing adoption of preventive healthcare, increasing demand for nootropic products, and a shift toward plant-based sources of phosphatidylserine, such as soy and sunflower. Furthermore, advancements in extraction and manufacturing processes have made phosphatidylserine more accessible and affordable, further boosting market growth. Emerging markets in Asia-Pacific and Latin America are also presenting lucrative opportunities due to rising disposable incomes and a growing focus on mental health.
Market Overview: Phosphatidylserine Gaining Traction
Phosphatidylserine is a naturally occurring phospholipid present in the human brain. It plays a crucial role in cognitive function and memory. The market for phosphatidylserine is witnessing increasing demand due to its growing applications in various sectors:
- Dietary Supplements: A significant portion of the market is driven by the use of phosphatidylserine in dietary supplements, particularly for promoting cognitive health and memory function in aging populations.
- Functional Foods: The rising trend of functional foods fortified with health-enhancing ingredients is creating opportunities for phosphatidylserine. Food and beverage manufacturers are incorporating phosphatidylserine to enhance the nutritional value of their products.
- Medical Foods: Phosphatidylserine holds promise for its potential benefits in managing neurological conditions like Alzheimer’s disease and dementia. Growing research in this area is expected to fuel demand in the pharmaceutical industry.
- Cosmetics: While currently a niche application, the use of phosphatidylserine in cosmetics is anticipated to grow as research delves into its potential benefits for skin health.
Several factors are propelling the growth of the phosphatidylserine market:
- Rising Health Consciousness: Consumers are increasingly focusing on preventive healthcare and natural solutions for maintaining cognitive health. This trend is driving demand for functional foods and dietary supplements containing phosphatidylserine.
- Aging Population: The global population is aging rapidly, with a growing number of individuals reaching ages where cognitive decline becomes a concern. This demographic shift is creating a larger target market for phosphatidylserine products.
- Growing Awareness of Cognitive Decline: Public awareness of conditions like Alzheimer’s disease and dementia is on the rise. This, coupled with the limited treatment options available, is leading individuals to explore alternative solutions like phosphatidylserine supplementation.
- Shift Towards Plant-based Products: The growing consumer preference for plant-based products is influencing the phosphatidylserine market. Manufacturers are increasingly sourcing phosphatidylserine from plant sources like soybeans to cater to this demand.
Development in the Market:
- NZMP milk phospholipid 70 was introduced in 2021 by the New Zealand-based Corporation Fonterra Co-Operative Group Ltd under the trade name NZMP. This phospholipid ingredient is suitable for many food and beverage products, such as nutritional bars, ready-to-mix health powders, and supplement sachets. It is specially formulated for the behavioral therapy and mental function under stress issues that have been magnified during the pandemic period.
Key Takeaways:
- The phosphatidylserine market is anticipated to reach a valuation of US$ 178.19 million in 2023.
- The low adoption rate of dietary supplements and functional foods in many emerging economies may restrain the market to some extent.
- The phosphatidylserine market recorded a CAGR of 9% from 2018 to 2022.
- The market in China is expected to record a CAGR of 6.7% over the forecast period.
- The phosphatidylserine market is expected to surpass US$ 298.1 million by 2033.
- Phosphatidylserine is in high demand because of its benefits for cognitive function. Its application in the food and pharmaceutical industries is expected to increase phosphatidylserine’s market share, thus this primary factor is expected to drive the
- The phosphatidylserine market is predicted to record a CAGR of 3% through 2033
- The market in the United Kingdom is expected to record a CAGR of 5.8% over the forecast period.
- The phosphatidylserine market reached a valuation of US$ 169.48 million in 2022
- The market in the United States is expected to record a CAGR of 5.6% over the forecast period.
Competitive Background:
The key players operating in the phosphatidylserine market are investing in mergers and acquisitions in order to gain a significant market share. The manufacturers are also investing in research and development, and are introducing innovative methods to boost production capacity. Product development and market expansion are significant aspects of the phosphatidylserine market. As a result, market participants are likely to have a better overall revenue share in the global phosphatidylserine market.
Access the full report for detailed market trends. https://www.futuremarketinsights.com/reports/phosphatidylserine-market
Significant Key Players in the Phosphatidylserine Market Include:
- Lonza AG
- Enzymotec Ltd
- Lipogen Products Ltd.
- Doosan Corporation
- Novastell
- Nagase ChemteX Corporation
- Bontac Bio-engineering (Shenzhen) Co. Ltd.
- ECA Healthcare, Inc.
- Lipoid GmbH
- Chemi Nutra LLC
- Others
Global Phosphatidylserine Market: Segmentation
By Form:
- Powder
- Liquid
By End Use:
- Functional Foods
- Dietary Supplements & Nutraceuticals
- Cosmetics & Personal Care
By Grade:
- Food Grade
- Pharmaceutical Grade
By Nature:
- Organic
- Conventional
By Source:
- Plant Source
- Soybean
- Sunflower
- Others (Cabbage etc.)
- Animal-derived
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- The Middle East & Africa
- Oceania
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
